Received Dec 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | W1C751M | OT |
expired ipol was administered with no reported ae; Initial information received on 26-Nov-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 years old male patient who was administered with expired IPV (VERO) [IPOL] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (Dtap) for Immunisation; Hepatitis a vaccine (Hepatitis a vaccine) for Immunisation; Hepatitis b vaccine (Hepatitis b vaccin) for Immunisation; and Pneumococcal vaccine conj 20v (CRM197) (Pneumococcal vaccine conj 20v (CRM197)) for Immunisation. On 25-Nov-2025, the patient received an expired Dose 1 with dosage 0.5 ml of suspect IPV (VERO) Suspension for injection (lot W1C751M, expiry: 18-Nov-2025, strength: standard) via intramuscular route in the thigh nos (not otherwise specified) as Immunization, with no reported adverse event (expired product administered) (Latency: same day). Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Dtap; Hepatitis a vaccine; Hepatitis b vaccin; Pneumococcal vaccine conj 20v (CRM197)